コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y has opened a new era of nucleic acid-based molecular diagnostics.
2 acter stool antigen CIDTs versus culture and molecular diagnostics.
3 nce the advent of antiretroviral therapy and molecular diagnostics.
4 nomics, small genome sequencing and clinical molecular diagnostics.
5 ith the naked eye is seemingly impossible in molecular diagnostics.
6 provide inexpensive and accessible advanced molecular diagnostics.
7 sents a breakthrough shift into a new era of molecular diagnostics.
8 ne expression would catalyze a revolution in molecular diagnostics.
9 verse range of DNA or RNA viruses by routine molecular diagnostics.
10 lead to a versatile and portable device for molecular diagnostics.
11 ated with the clinical adoption of WGS-based molecular diagnostics.
12 n most HCCs and provides a unique target for molecular diagnostics.
13 They have been approved as therapeutics and molecular diagnostics.
14 ntially useful as bright contrast agents for molecular diagnostics.
15 ion studies, signalling pathway analysis and molecular diagnostics.
16 computation and as applied as point-of-care molecular diagnostics.
17 development of true point-of-care tests for molecular diagnostics.
18 logy applications related to targeted enzyme molecular diagnostics.
19 can cause ocular inflammation by serology or molecular diagnostics.
20 ge of potential applications in clinical and molecular diagnostics.
21 at potential for biomedical applications and molecular diagnostics.
22 g as well as emerging approaches in clinical molecular diagnostics.
23 ovides more 'tools' for DNA manipulation and molecular diagnostics.
24 which is of great interest in genotyping and molecular diagnostics.
25 ation is becoming increasingly important for molecular diagnostics.
26 testing, and management are all dependent on molecular diagnostics.
27 DNA sample before sequencing is critical in molecular diagnostics.
28 resolution, providing a robust platform for molecular diagnostics.
29 iation, disease susceptibility, and clinical molecular diagnostics.
30 to a number of applications in the field of molecular diagnostics.
31 e disease genes has allowed establishment of molecular diagnostics.
32 ed in many fields of biomedical research and molecular diagnostics.
33 Banff working groups, and standardization of molecular diagnostics.
34 ow-complexity, highly sensitive and accurate molecular diagnostics.
35 ially an important clinical marker in cancer molecular diagnostics.
36 nd outcomes related to the use of SARS-CoV-2 molecular diagnostics.
37 sequences yield unique genome signatures for molecular diagnostics.
38 nomics revolution (e.g., microarrays) and of molecular diagnostics.
39 biology and is poised to enter the field of molecular diagnostics.
40 ll also greatly assist in drug discovery and molecular diagnostics.
41 bes makes this method attractive for routine molecular diagnostics.
42 mechanisms is poor, which is hampering rapid molecular diagnostics.
43 aditional stool microscopy, despite gains in molecular diagnostics.
44 Endonucleases have recently widely used in molecular diagnostics.
45 tool for advanced quantitative screening in molecular diagnostics.
46 ture research directions toward democratized molecular diagnostics.
47 applications in gene expression analysis and molecular diagnostics.
48 uture taxonomy enrichments based on emerging molecular diagnostics.
49 l slider cassette designed for point-of-care molecular diagnostics.
50 the potential to revolutionize the field of molecular diagnostics.
51 , reinforcing its potential for quantitative molecular diagnostics.
52 aded platinum nanoparticles to develop novel molecular diagnostics.
53 n detection has wide-ranging implications in molecular diagnostics.
54 development of next-generation point-of-care molecular diagnostics.
55 to transmission, were detectable by standard molecular diagnostics.
56 and sustainability of machine learning-based molecular diagnostics.
57 ation to guide therapy and, potentially, for molecular diagnostics.
58 rs, promising a new wave of simple and rapid molecular diagnostics.
59 ent ability to exploit the full potential of molecular diagnostics.
60 cacies, have recently become supplemented by molecular diagnostics.
61 leic acid sequences is a major bottleneck in molecular diagnostics.
62 ow volume, high throughput opportunities for molecular diagnostics.
63 h-throughput polymerase chain reaction (PCR) molecular diagnostics, a method was developed to rapidly
64 ents will include simpler and less expensive molecular diagnostics, advances in the understanding of
65 Here, we present acoustofluidic integrated molecular diagnostics (AIMDx) on a chip, a platform enab
67 hat scientific and technological advances in molecular diagnostics and bioinformatics are well integr
69 e potential to offer simple sample-to-answer molecular diagnostics and can inform healthcare workers
71 ility and virulence and could render current molecular diagnostics and countermeasures ineffective.
72 genetic variants with phenotype improve both molecular diagnostics and drug discovery and offer clini
74 nal efforts focused on using these tools for molecular diagnostics and for the discovery of therapeut
75 d cancer; new approaches in chemoprevention, molecular diagnostics and genetic testing, and therapy;
77 rcomes existing limitations in exosome-based molecular diagnostics and holds a powerful position for
78 ction imaging provides new opportunities for molecular diagnostics and image-guided biomedical applic
80 ntions should include a combination of rapid molecular diagnostics and improved chemotherapy to short
81 antibody testing, transplantation pathology, molecular diagnostics and laboratory support for the inc
84 aining increasing attention in the fields of molecular diagnostics and nanomedicine for the delivery
85 pands the utility of nanopore sequencing for molecular diagnostics and other applications, especially
86 the potential of alphavbeta8 as a target for molecular diagnostics and personalized therapy regimens.
88 ogy research and the development of improved molecular diagnostics and prevention schemes for this ne
89 rgan systems, has the potential to transform molecular diagnostics and prognostics while uncovering n
92 ity of the virus, which has implications for molecular diagnostics and the design of potential vaccin
93 noninvasive methods of diagnosis as well as molecular diagnostics and their merits and shortcomings
98 tion patterns has major potential to advance molecular diagnostics and underpin research investigatio
99 proaches, including applications of advanced molecular diagnostics and vaccine probe studies, as well
100 EOC, and consequently may serve as important molecular diagnostics and/or therapeutic targets for the
101 of synthetic biology in vaccine development, molecular diagnostics, and cell-based therapeutics, emph
103 represents one of the greatest challenges in molecular diagnostics, and remains an unsolved problem.
104 regulation, drug delivery, gene therapy, and molecular diagnostics, and show promise for both antisen
105 algorithm using symptoms, chest radiography, molecular diagnostics, and tuberculin skin testing.
107 a robust pipeline of new tools, particularly molecular diagnostics, and well over 50 companies active
108 the goals of understanding their genomes for molecular diagnostics applications, vaccine redevelopmen
109 nable to identify active state of infection, molecular diagnostics are an effective means to detect Z
110 which could lead to amplification bias when molecular diagnostics are applied for L. pneumophila det
117 order to counter the common perception that molecular diagnostics are too complicated to work in low
118 amplification (LAMP) is increasingly used in molecular diagnostics as an alternative to PCR based met
119 as major implications for the future of both molecular diagnostics as well as cancer chemotherapy.
120 nostics and protein analysis, cell handling, molecular diagnostics, as well as food, water, and soil
121 l to enable single cell studies for advanced molecular diagnostics, as well as wider applications in
122 or obstacles to implement nucleic acid-based molecular diagnostics at the point-of-care (POC) and in
125 ave important applications in ultrasensitive molecular diagnostics, bioterrorism agent detection, and
126 ing (NGS) is emerging as a powerful tool for molecular diagnostics but remains limited by cumbersome
127 studies designed to help evaluate new rapid molecular diagnostics by developing, testing, and applyi
128 ection of RNA has the potential to transform molecular diagnostics by enabling simple on-site analysi
129 e properties of Argonaute (Ago) proteins for molecular diagnostics by introducing an artificial nucle
130 tence should encourage the implementation of molecular diagnostics by National Tuberculosis Programme
134 oration of D-cycloserine resistance in novel molecular diagnostics could allow for targeted use of th
135 ore, we felt a need for more evidence before molecular diagnostics could be routinely integrated and
138 s are major players in the race for improved molecular diagnostics due to their convenience, temporal
139 Medical Director, Clinical Microbiology and Molecular Diagnostics, Dynacare Laboratories, and Froedt
142 diagnostics, improvement and advancement of molecular diagnostics, emerging diagnostics, including r
143 which would not be detected by current rapid molecular diagnostics employed in South Africa that asse
146 ibility, aptamers have sparked innovation in molecular diagnostics, enabled advances in synthetic bio
147 ast data in combination with advancements in molecular diagnostics enables much greater precision in
148 pplications related to analytical chemistry, molecular diagnostics, environmental monitoring, and nat
149 red gene circuits, bring new capabilities to molecular diagnostics, expanding the molecular detection
155 t decade, this work has spawned a new era of molecular diagnostics for early detection of this condit
156 d therapy selection.1,2 Rapid and accessible molecular diagnostics for fusion-driven leukemias such a
157 2019 (COVID-19) pandemic, during which time molecular diagnostics for infectious diseases have assum
158 e systems for nematode-pest-crop management: molecular diagnostics for nematode identification, genet
159 used to exponentially increase the signal in molecular diagnostics for nucleic acids, but there are n
162 mercially available rapid (results <3 hours) molecular diagnostics for respiratory viruses as compare
163 ection could allow the development of rapid, molecular diagnostics for sCJD and has implications for
164 assays has resulted in the increased use of molecular diagnostics for the routine detection of HSV i
165 The development and implementation of rapid molecular diagnostics for tuberculosis (TB) drug-suscept
166 to facilitate their use in applications like molecular diagnostics, force sensing, and nanorobotics t
167 has played a major role in the transition of molecular diagnostics from research to routine clinical
168 properties spanning the fields of chemistry, molecular diagnostics, gene regulation, medicine, and ma
172 re than a century, the recent development of molecular diagnostics has shed new light on the origin a
182 setting, this study shows the potential for molecular diagnostics in ADPKD that is likely to become
183 importance of an epidemiological history and molecular diagnostics in ascertaining insights into tran
184 strong contender for versatile and portable molecular diagnostics in both research and clinical sett
185 y of employing a sample pooling strategy for molecular diagnostics in clinical and epidemiologic mala
187 l practice can improve drug use by providing molecular diagnostics in concert with molecular therapeu
188 es on the relative merits of 3 approaches to molecular diagnostics in hematologic malignancies: indic
192 of next generation sequencing platforms for molecular diagnostics in non-small-cell lung cancer is i
194 ies continue to be driven by developments in molecular diagnostics in pediatric genitourinary tumors.
195 -specific antibodies; the potential value of molecular diagnostics in such cases and recommendations
196 t practical limitations to the deployment of molecular diagnostics in the field and demonstrates how
199 rtant implications for the interpretation of molecular diagnostics, including identifying patients at
200 cine has engendered a need for corresponding molecular diagnostics, including noninvasive molecular i
203 . influenzae in CSF, and that application of molecular diagnostics is a feasible way to enhance local
205 espoke diagnosis and treatment, this area of molecular diagnostics is beginning to see an upsurge in
213 In the field of rare diseases, progress in molecular diagnostics led to the recognition that varian
214 c evaluation, cyst fluid analysis, and novel molecular diagnostics, many of these lesions remain diff
215 uture work with contact tracing and advanced molecular diagnostics may allow for identification of MR
218 demiologic investigation in conjunction with molecular diagnostics may enable early identification of
222 s performed to evaluate the caveats of using molecular diagnostics (MDX) to distinguish between these
223 tors has significant advantages (simplifying molecular diagnostics methods, reducing size, time, and
224 challenges and opportunities for developing molecular diagnostics needed to support STH control effo
225 ditary spastic paraplegia (HSP), progress in molecular diagnostics needs to be translated into robust
228 f growing practical interest with respect to molecular diagnostics of cancer, infectious and genetic
229 ations of this sampling methodology to rapid molecular diagnostics of cutaneous allergies and infecti
230 in biofluids are emerging biomarkers for the molecular diagnostics of diseases, but their clinical us
231 -of-concept bioassay for simple and portable molecular diagnostics of emerging pathogens using electr
236 iency is associated with muscular dystrophy, molecular diagnostics of the plectin gene provides progn
237 we demonstrate a Lab-on-paper for all-in-one molecular diagnostics of zika, dengue, and chikungunya v
241 rization based on guidelines, utilization of molecular diagnostics, particularly kinase domain mutati
251 ased RFLP to make it a faster format, DuPont Molecular Diagnostics recently introduced the IS6110-Pvu
254 e of the limited signal-to-background ratio, molecular diagnostics requires molecular amplification o
257 istance, particularly katG p.Ser315Thr, into molecular diagnostics should enable targeted treatment o
259 ein assays, which are highly sought after in molecular diagnostics such as cancer diagnosis and treat
262 nd fully automated Beckman Coulter DxN Veris Molecular Diagnostics System (DxN Veris System) was eval
263 ostics system is also known as the Veris MDx molecular diagnostics system and the Veris MDx system.).
264 eliminary results of a portable and low-cost molecular diagnostics system for ZIKV infection are repo
266 w, fully automated Beckman Coulter DxN Veris molecular diagnostics system was evaluated at 10 Europea
268 ancer treatment, the growing availability of molecular diagnostics techniques may help in identifying
270 chemistry and detection continue to improve molecular diagnostics technology, blood samples are stil
271 ights into disease pathogenesis, and lead to molecular diagnostics that can be used to optimize the t
275 Our findings enabled the development of molecular diagnostics that we used to confirm persistenc
276 practice of oncology is being transformed by molecular diagnostics that will enable predictive and pe
279 noassays are fundamental analytical tools in molecular diagnostics, therapy monitoring and drug disco
281 nator health and the utility of colony-level molecular diagnostics to assess environmental suitabilit
282 ing results encourage further development of molecular diagnostics to be used with whole blood for de
283 ides a novel way for molecular therapies and molecular diagnostics to come together in the discovery
284 I) to establish and monitor hypomyelination, molecular diagnostics to determine a specific etiology,
285 oring the potential benefit of comprehensive molecular diagnostics to enable early antibiotic optimiz
286 ere is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19-positive pati
287 these newly discovered allergens will enable molecular diagnostics to identify patients at high risk
288 , to develop novel diagnostic techniques and molecular diagnostics, to establish a program for identi
292 hment system (HOLMES) for amplification-free molecular diagnostics using massively paralleled and hie
294 tral to modern molecular biology and also to molecular diagnostics where identification of a particul
296 /strain level discrimination, is critical in molecular diagnostics with major impacts in areas such a
297 indicate damage to brain tissue could yield molecular diagnostics with the potential to improve how